Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and Dexamethasone in Newly Diagnosed ITP
NCT00909077Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Aug 2004
- Primary completion
- Jun 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in immune thrombocytopenia (ITP), sponsored by Rigshospitalet. Started Aug 2004; status: completed.
02
Drugs
rituximab
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT00909077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00909077.